Article at a Glance:

From producing life-saving insulin in bacteria to designing entirely new biological systems, molecular cloning is the engine that drives modern biotechnology. But this powerful toolkit wasn't created overnight; it's the result of 50 years of innovation, evolving from a slow, painstaking process into a suite of lightning-fast, precise techniques.

This guide covers:

• Why did scientists need to clone DNA?
• How does traditional Restriction Cloning work?
• How did PCR lead to TA Cloning?
• What are the differences between Golden Gate and Gateway Cloning?
• What are the differences between Gibson Assembly and In-Fusion Cloning?
• How is software changing molecular cloning?

The Spark of Discovery: Why do we clone DNA?

The Challenge of a Black Box Genome

In the mid-20th century, biology was undergoing a profound revolution. Scientists had firmly established that DNA was the hereditary material and, thanks to Francis Crick's "Central Dogma" proposed in 1957, they had a foundational framework for how genetic information flows within a cell: DNA is transcribed into RNA, and RNA is translated into protein [1] [2].

This elegant principle explained how the blueprint of life is read and used, but it also highlighted an enormous challenge. For scientists, the genome of an organism was like a vast, inscrutable library containing thousands of books, with each book representing a single gene. They knew the library held the secrets to virtually every biological process, but they had no way to check out, read, or even find a specific book. Until the 1970s, methods to isolate individual genes simply did not exist. Researchers were left to study genes indirectly, observing the effects of mutations without being able to grasp the underlying molecular machinery. The complete genome was a "black box"; they could see what went in (environmental factors) and what came out (physical traits), but the specific genetic instructions responsible remained locked away, preventing a deep, mechanistic understanding of life itself.

The Need for Gene Isolation

This inability to isolate genes was a major roadblock to answering some of the most critical questions in science and medicine. The desire to understand and combat diseases was a powerful motivator. Scientists hypothesized that specific faulty genes were responsible for inherited disorders, but to prove it, they needed to isolate and compare the healthy and mutated versions of a gene. Furthermore, the dream of producing therapeutic proteins on a large scale seemed like pure science fiction. A prime example was insulin. Before the advent of genetic engineering, the millions of people with diabetes relied on insulin extracted from the pancreases of cows and pigs. This animal-derived insulin was effective but was also impure, expensive to produce, and caused allergic reactions in some patients. Researchers knew that if they could somehow harness the human insulin gene, they could use fast-growing bacteria like E. coli as microscopic factories to produce a limitless supply of pure, human insulin [3][4]. This vision (to produce life-saving medicines, to unravel the genetic basis of disease, to understand the fundamental function of each part of the genome) created an urgent and powerful need. The scientific community didn't just want to read the book of life; they needed to be able to pull a single page out, copy it, and study it in detail. This driving need is what set the stage for the invention of molecular cloning.

What were the First Molecular Cloning Methods?

The monumental leap from theory to practice required the discovery of a specific set of biological tools capable of manipulating DNA with surgical precision. Forging this toolkit did not happen overnight, but was the result of several independent lines of inquiry that converged in the late 1960s and early 1970s. These discoveries provided the essential "scissors," "glue," and "delivery vehicles" needed to build the first artificial genetic molecules.

Restriction Enzymes: The Molecular Scissors

The first major breakthrough came from an unexpected source: the study of how bacteria defend themselves against invading viruses. In the 1960s, researchers including Werner Arber and Matthew Meselson independently observed that some bacteria could chop up the DNA of bacteriophages (viruses that infect bacteria), effectively "restricting" their growth. They hypothesized that the bacteria possessed a defence system that could recognize and destroy foreign DNA [5][6]. This work culminated in Hamilton Smith's 1970 isolation of the first site-specific restriction enzyme, HindII. Smith demonstrated that this enzyme didn't just cut DNA randomly; it recognized a specific sequence of nucleotides and cleaved the DNA molecule at that exact point [7]. Soon after, Daniel Nathans showed that these enzymes, which he called restriction enzymes, could be used to create a defined map of a viral genome [8]. The implications were staggering. For the first time, scientists had "molecular scissors" that allowed them to cut a large, complex genome into specific, predictable, and manageable fragments. This was the key that finally unlocked the genome for targeted manipulation and was honoured with the 1978 Nobel Prize for Daniel, Hamilton and Werner [9].

DNA Ligase: The Molecular Glue

Having a way to cut DNA was revolutionary, but it was only half the battle. To create a new genetic sequence, scientists also needed a way to paste different DNA fragments together. That tool, known as DNA ligase, was discovered in several labs in 1967 [10][11][12][13]. DNA ligase is a crucial enzyme that all organisms use to repair breaks in their DNA backbone during processes like replication and repair. Biochemists realized that this "molecular glue" could be harnessed to permanently join separate pieces of DNA in a test tube. Specifically, it could form a stable phosphodiester bond between the sugar-phosphate backbones of two DNA fragments. When combined with the action of restriction enzymes (many of which leave "sticky ends," short, single-stranded overhangs that naturally want to pair up) DNA ligase became the essential counterpart to the molecular scissors. Now, a fragment of DNA from one organism could be cut out and seamlessly pasted into the DNA of another.

The First Recombinant DNA

The stage was now set for one of the most important experiments in the history of biology. In 1972, Paul Berg and his team successfully used these tools to create the first man-made recombinant DNA molecule by ligating DNA from a monkey virus (SV40) with DNA from a bacterial virus [14]. While a landmark achievement, Berg initially deferred the final step of introducing this molecule into live bacteria due to safety concerns. That final, crucial step was taken in 1973 by Stanley Cohen and Herbert Boyer. They took a plasmid (a small, circular piece of DNA that replicates independently inside bacteria) and used a restriction enzyme to cut it open. Using the same enzyme, they excised a gene conferring antibiotic resistance from another plasmid. With DNA ligase, they pasted this gene into the first plasmid, creating a new, functional, recombinant plasmid. They then introduced this engineered plasmid into E. coli bacteria and demonstrated two critical things: first, the bacteria survived and replicated, and second, all of their offspring inherited the plasmid and its new antibiotic resistance [15]. This experiment proved that a specific piece of foreign DNA could be introduced into a host organism and be faithfully copied, or "cloned," for generations. The era of molecular cloning had officially begun.

What is Restriction Cloning and How Does it Work?

The successful experiments of the early 1970s quickly gave rise to a standardized and widely adopted methodology known as restriction (enzyme) cloning. This workflow became the bedrock of molecular biology for decades, empowering a generation of scientists to isolate and manipulate genes for the first time. It is a true "cut and paste" technique that relies on the foundational tools of restriction enzymes and DNA ligase to insert a specific piece of DNA into a plasmid vector, which can then be replicated inside a host organism like E. coli.

The principle behind restriction cloning is conceptually simple. The process begins with two key DNA molecules: the vector, typically a circular plasmid engineered to contain an origin of replication, a selectable marker (like an antibiotic resistance gene), and a series of unique restriction enzyme cut sites clustered together (known as a multiple cloning site); and the insert (the target gene or DNA fragment to be cloned).

The core of the method involves a "digest" reaction. Both the plasmid vector and the DNA insert are cut with the same restriction enzyme or, more commonly, a pair of different restriction enzymes. This enzymatic digestion creates compatible ends on both molecules. Many restriction enzymes create a short, single-stranded overhang known as a "sticky end." By cutting the vector and insert with the same enzyme, their sticky ends become complementary, allowing them to anneal with each other. Using two different enzymes ensures that the insert can only be integrated in a specific orientation, a crucial refinement known as directional cloning.

Once digested, the insert and the linearized vector are mixed together in a test tube. The complementary sticky ends anneal, temporarily holding the insert in place within the vector's backbone. At this stage, DNA ligase is added. Acting as the molecular glue, it permanently joins the insert to the vector by forming strong phosphodiester bonds, creating a single, seamless, recombinant plasmid.

The final challenge is to identify the few bacteria that have successfully taken up the correct recombinant plasmid. This is achieved through a multi-step screening process. First, the entire mixture is introduced into E. coli, and the bacteria are grown on a petri dish containing an antibiotic. Only the bacteria that successfully incorporated any plasmid (which contains the resistance gene) will survive. However, this doesn't distinguish between bacteria that took up the desired plasmid (with the insert) and those that took up a plasmid that simply closed back on itself. To solve this, clever vectors were designed for "blue-white screening." These vectors contain the lacZ gene, which produces an enzyme that turns a specific chemical blue. The multiple cloning site is placed right in the middle of this gene. If the DNA insert is successfully ligated into the vector, it disrupts the lacZ gene, which can no longer produce the enzyme. As a result, bacterial colonies containing the correct recombinant plasmid appear white, while colonies with the empty, re-ligated plasmid appear blue, making it easy for researchers to visually identify and pick the successful clones [16][17].

Despite its revolutionary impact, restriction cloning has significant limitations that often make it a slow and frustrating process. The entire workflow is dependent on the presence of suitable restriction sites flanking the gene of interest and within the vector, which are often not where you need them to be. Furthermore, the process leaves behind the restriction site sequence in the final DNA construct, creating a small "scar" that can be problematic for certain applications, like protein engineering. The method is also prone to failure, with common issues like the vector re-ligating to itself, and requires multiple purification steps and several days to complete. It was these very limitations that drove the scientific community to develop the faster, more flexible, and more efficient cloning methods that characterize the modern era.

To see a step-by-step guide and visualize how these enzymes and plasmids work together, you can watch our detailed tutorial on Restriction Cloning.

How did PCR Revolutionize Molecular Cloning?

While restriction cloning gave scientists the ability to manipulate DNA, the process could still be cumbersome and inefficient. A significant bottleneck was the need to obtain a sufficient quantity of the target DNA insert, often requiring tedious purification from biological samples. The next great leap forward in molecular biology would address this very problem, and in doing so, would not only streamline the classic workflow but also give rise to entirely new and simpler methods of cloning.

The PCR Discovery

In 1983, a discovery was made that would fundamentally change the landscape of biological research and earn Kary Mullis a Nobel Prize. That discovery was the Polymerase Chain Reaction, or PCR. At its core, PCR is a method for making millions to billions of copies of a specific DNA segment in a matter of hours. By using short, synthetic DNA strands called primers to flank a target region and a heat-stable DNA polymerase enzyme, the process cycles through heating and cooling steps to repeatedly denature the DNA, anneal the primers, and extend them to create copies [18][19][20]. This exponential amplification was nothing short of revolutionary.

For molecular cloning, PCR was a game-changer for two main reasons. First, it democratized the process by making the starting material readily accessible. Scientists no longer needed a large, purified sample of a genome; they could now amplify a target gene from even a single cell or a minute amount of source DNA. Second, it gave researchers unprecedented control over the DNA insert. The primers used in the PCR reaction could be designed with extra sequences on their ends, allowing scientists to easily add specific restriction enzyme sites to the amplified fragment. This simple addition provided a powerful workaround to one of restriction cloning's biggest limitations, as it eliminated the dependence on naturally occurring cut sites.

What is TA Cloning?

The widespread adoption of PCR soon led to the development of cloning techniques designed specifically to capitalize on its properties. One of the most elegant and popular of these is TA Cloning. This method cleverly exploits a peculiar feature of Taq polymerase, the workhorse enzyme used in most standard PCR reactions. As Taq polymerase copies DNA, it has a natural tendency to add a single, untemplated adenine (A) nucleotide to the 3' end of each newly synthesized strand [21].

Instead of treating this as a problem, scientists turned it into a solution. They developed specialized cloning vectors that are supplied in a linearized form with a single thymine (T) nucleotide overhanging at each 3' end. The principle is straightforward: the adenine overhang on the PCR product is perfectly complementary to the thymine overhang on the vector. When the PCR product and the "T-vector" are mixed together, the complementary A and T bases anneal, holding the insert in place just long enough for DNA ligase to be added to seal the nicks and create a stable, circular plasmid [22].

The main advantage of TA cloning is its remarkable speed and simplicity. It allows a researcher to take a freshly amplified PCR product and, in a single step, ligate it directly into a vector without any need for restriction digests or subsequent cleanup. This eliminates several time-consuming steps from the traditional workflow and avoids the potential complication of the chosen restriction enzyme cutting within the insert itself. For quickly cloning and sequencing a PCR product, TA cloning became, and remains, a highly efficient and go-to method.

To better understand how the A- and T-overhangs interact and lead to a successful clone, check out our visual guide in the TA Cloning tutorial.

What are the Modern Molecular Cloning methods?

As the ambitions of biologists grew, so did the limitations of traditional cloning methods. The rise of fields like synthetic biology and metabolic engineering, where scientists needed to construct entire pathways involving multiple genes, demanded tools that were more robust, reliable, and flexible than ever before. This need catalyzed the development of a new generation of cloning techniques that could seamlessly assemble multiple DNA fragments in a single reaction, offering unprecedented speed and control. These modern methods moved away from the rigid constraints of restriction sites, instead leveraging clever enzymatic properties to build complex DNA constructs quickly and with precision.

What is Golden Gate Assembly?

One of the most powerful and elegant of these modern techniques is Golden Gate Assembly. This method revitalized the use of restriction enzymes by focusing on a special class known as Type IIs restriction enzymes. Unlike standard restriction enzymes that cut within their recognition sequence, Type IIs enzymes bind to their specific site but cut the DNA several base pairs downstream [23]. This unique property is the key to Golden Gate's power. It allows researchers to design DNA fragments where the recognition site is placed at the very edge, so that when the enzyme cuts, the recognition site itself is removed, leaving behind a custom, four-base "sticky end."

The true elegance of Golden Gate lies in its "one-pot" assembly process. Multiple DNA fragments (e.g., a promoter, a gene, and a terminator) and a destination vector are designed so that the sticky end of one fragment is complementary only to the sticky end of its intended neighbor. All of these pieces are then combined in a single tube with both the Type IIs enzyme (like BsaI) and DNA ligase. The reaction is cycled between temperatures optimal for cutting and ligating. Because the final, correctly assembled plasmid no longer contains the Type IIs recognition sites, it is immune to being cut again. In contrast, any incorrect ligations or original plasmids are repeatedly cut apart, driving the reaction irreversibly towards the desired final product [24][25].

The advantages of this method are enormous. It enables the ordered and oriented assembly of many DNA fragments (often 10 or more) in a single, highly efficient reaction. Furthermore, because the recognition sites are cleaved off during the process, the final construct is perfectly seamless, with no unwanted "scar" sequences left between the parts. This has made Golden Gate a cornerstone of synthetic biology, enabling the creation of standardized, modular DNA parts that can be easily interchanged and assembled into novel genetic circuits.

To see how Type IIs enzymes work and how to design a multi-part assembly reaction, watch our detailed guide in the Golden Gate Assembly tutorial.

Seamless and Sequence Independent Methods

While Golden Gate perfected the use of custom sticky ends, another branch of cloning evolution sought to eliminate the need for restriction enzymes altogether. The goal was to develop methods where any two pieces of DNA could be joined together, regardless of their sequence. This led to the creation of powerful assembly techniques that rely on generating short regions of homology, or "overlaps," at the ends of DNA fragments, which then guide the assembly process. These methods offered the ultimate flexibility, giving researchers the freedom to build DNA constructs with a level of ease and precision previously unimaginable.

What are In-Fusion Cloning and Hi-Fi DNA Assembly?

In-Fusion cloning and similar methods like Hi-Fi DNA Assembly are based on the principle of homologous recombination. The process begins by generating the DNA insert (via PCR) with short, 15-25 base pair overlaps at its ends that are identical to the sequences at the ends of the linearized destination vector. The vector and insert are then mixed with a specialized enzyme blend containing an exonuclease. This exonuclease "chews back" one strand of the DNA from the 3' end, exposing single-stranded tails. The complementary tails on the insert and vector then anneal, creating a stable intermediate. Once this molecule is transformed into E. coli, the bacteria's own natural DNA repair machinery recognizes the nicks and gaps and permanently seals the construct, resulting in a seamless, scar-free plasmid [26]. This approach is incredibly versatile, as it does not depend on any specific sequence other than the short overlaps, which can be easily added during PCR.

See this elegant process in action and learn how to design the required overlaps in our In-Fusion / Hi-Fi tutorial.

What is Gibson Assembly?

Gibson Assembly, developed by Daniel Gibson in 2009, takes the concept of overlap-based assembly a step further by creating a robust "one-pot" reaction that fully assembles the DNA construct in vitro. It relies on a cocktail of three different enzymes and requires DNA fragments with longer homologous overlaps of 20-40 base pairs. In the reaction, a 5' exonuclease chews back the DNA ends to expose single-stranded overhangs, which then anneal. A high-fidelity DNA polymerase then fills in any gaps. Finally, a DNA ligase seals the remaining nicks in the DNA backbone. This powerful combination allows for the seamless joining of multiple DNA fragments in a single, isothermal reaction. Gibson Assembly is particularly celebrated for its ability to create very large DNA constructs, such as entire synthetic genomes, making it an invaluable tool for complex and ambitious synthetic biology projects [27].

For a visual breakdown of how the three enzymes work together to assemble multiple DNA parts, be sure to watch our Gibson Assembly tutorial.

What is Gateway Cloning? What is BP and LR Cloning?

Moving in a completely different direction from restriction- or overlap-based methods, Gateway Cloning offers a highly standardized and efficient system for moving DNA fragments between different vectors. Instead of using restriction enzymes or ligases to "cut and paste," Gateway uses the site-specific recombination machinery from the bacteriophage lambda. This system is less about de novo assembly and more about creating a reusable library of DNA parts that can be shuttled between various functional contexts with exceptional speed and reliability.

The process is a clever two-step workflow. The first step, the BP Reaction, creates a standardized "Entry Clone." A target gene, amplified by PCR with flanking attB sites, is mixed with a Donor Vector containing attP sites. An enzyme mix called BP Clonase catalyzes a recombination event between the attB and attP sites, moving the gene into the Donor Vector to create the Entry Clone. This clone now has the gene flanked by new attL sites and serves as the master copy.

The second step, the LR Reaction, is where the system's power shines. This Entry Clone can now be mixed with any compatible Destination Vector (e.g., for expression in bacteria, yeast, or mammalian cells) that contains attR sites. An LR Clonase enzyme mix catalyzes recombination between the attL and attR sites, seamlessly moving the gene of interest from the Entry Clone into the new Destination Vector [28][29]. The main advantage of Gateway is its parallel nature; once an Entry Clone is made, the same gene can be moved into dozens of different Destination Vectors in a single afternoon. This makes it the gold standard for high-throughput studies, such as large-scale protein expression and functional analysis projects.

To master this powerful two-step system, explore our tutorials on the Gateway BP Reaction and the Gateway LR Reaction.

What is the Future of Molecular Cloning?

The evolution of molecular cloning has been a relentless march towards greater speed, precision, and complexity. The journey from the painstaking work of the 1970s to the powerful one-pot reactions of today has transformed biology. Yet, the innovation continues. We are now entering an era where the lines between reading, editing, and writing DNA are blurring, driven by advances in DNA synthesis, automation, and the indispensable role of sophisticated software in navigating this new landscape.

The Role of Software in Modern Cloning

This explosion of powerful and complex cloning techniques has created a new challenge: managing the design. Planning a multi-part Golden Gate assembly, designing primers with precise 40-base pair homologous overlaps for Gibson Assembly, or keeping track of hundreds of Gateway Entry Clones is no longer feasible with just a pen and paper. The complexity of modern molecular biology demands tools that can handle intricate designs, prevent costly errors, and maintain a clear, accurate record of every step.

This is where specialized software for plasmid design and virtual cloning has become not just a convenience, but an absolutely essential tool for the modern molecular biologist. Platforms like Photo51, the plasmid editor, serve as the digital workbench for today's research. They allow scientists to simulate entire cloning workflows before ever picking up a pipette, automatically designing the necessary primers and flagging potential issues like unintended restriction sites. This virtual planning allows for the seamless visualization of complex constructs, ensuring that every fragment is in the correct order and orientation. Furthermore, these tools create a permanent, shareable, and fully annotated digital record of the final plasmid, which is crucial for reproducibility and collaboration. In this new era, advanced plasmid design platforms such as Photo51 make it possible to plan complex assemblies with confidence and accuracy, transforming cloning from a manual process into a streamlined digital workflow.

Citations

[1] Crick, F. H. (1958, January). On protein synthesis. In Symp soc exp biol (Vol. 12, No. 138-63, p. 8).

[2] Crick, F. (1970). Central dogma of molecular biology. Nature, 227(5258), 561-563.

[3] Goeddel, D. V., Kleid, D. G., Bolivar, F., Heyneker, H. L., Yansura, D. G., Crea, R., ... & Riggs, A. D. (1979). Expression in Escherichia coli of chemically synthesized genes for human insulin. Proceedings of the National Academy of Sciences, 76(1), 106-110.

[4] Riggs, A. D. (2021). Making, cloning, and the expression of human insulin genes in bacteria: the path to Humulin. Endocrine reviews, 42(3), 374-380.

[5] Arber, W., & Dussoix, D. (1962). Host specificity of DNA produced by Escherichia coli: I. Host controlled modification of bacteriophage λ. Journal of molecular biology, 5(1), 18-36.

[6] Meselson, M., & Yuan, R. (1968). DNA restriction enzyme from E. coli. Nature, 217(5134), 1110-1114.

[7] Smith, H. O., & Welcox, K. W. (1970). A restriction enzyme from Hemophilus influenzae: I. Purification and general properties. Journal of molecular biology, 51(2), 379-391.

[8] Danna, K., & Nathans, D. (1971). Specific cleavage of simian virus 40 DNA by restriction endonuclease of Hemophilus influenzae. Proceedings of the National Academy of Sciences, 68(12), 2913-2917.

[9] https://www.nobelprize.org/prizes/medicine/1978/summary/

[10] Gellert, Martin. "Formation of covalent circles of lambda DNA by E. coli extracts." Proceedings of the National Academy of Sciences 57, no. 1 (1967): 148-155.

[11] Weiss, B., & Richardson, C. C. (1967). Enzymatic breakage and joining of deoxyribonucleic acid, I. Repair of single-strand breaks in DNA by an enzyme system from Escherichia coli infected with T4 bacteriophage. Proceedings of the National Academy of Sciences, 57(4), 1021-1028.

[12] Olivera, B. M., & Lehman, I. R. (1967). Linkage of polynucleotides through phosphodiester bonds by an enzyme from Escherichia coli. Proceedings of the National Academy of Sciences, 57(5), 1426-1433.

[13] Cozzarelli, N. R., Melechen, N. E., Jovin, T. M., & Kornberg, A. (1967). Polynucleotide cellulose as a substrate for a polynucleotide ligase induced by phage T4. Biochemical and biophysical research communications, 28(4), 578-586.

[14] Jackson, D. A., Symons, R. H., & Berg, P. (1972). Biochemical method for inserting new genetic information into DNA of Simian Virus 40: circular SV40 DNA molecules containing lambda phage genes and the galactose operon of Escherichia coli. Proceedings of the National Academy of Sciences, 69(10), 2904-2909.

[15] Cohen, S. N., Chang, A. C., Boyer, H. W., & Helling, R. B. (1973). Construction of biologically functional bacterial plasmids in vitro. Proceedings of the National Academy of Sciences, 70(11), 3240-3244.

[16] Ullmann, A., Jacob, F., & Monod, J. (1967). Characterization by in vitro complementation of a peptide corresponding to an operator-proximal segment of the β-galactosidase structural gene of Escherichia coli. Journal of molecular biology, 24(2), 339-343.

[17] Vieira, J., & Messing, J. (1982). The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene, 19(3), 259-268.

[18] Saiki, R. K., Scharf, S., Faloona, F., Mullis, K. B., Horn, G. T., Erlich, H. A., & Arnheim, N. (1985). Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science, 230(4732), 1350-1354.

[19] Saiki, R. K., Gelfand, D. H., Stoffel, S., Scharf, S. J., Higuchi, R., Horn, G. T., ... & Erlich, H. A. (1988). Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science, 239(4839), 487-491.

[20] Mullis, K. B. (1990). The unusual origin of the polymerase chain reaction. Scientific American, 262(4), 56-65.

[21] Clark, J. M. (1988). Novel non-templated nucleotide addition reactions catalyzed by procaryotic and eucaryotic DNA polymerases. Nucleic acids research, 16(20), 9677-9686.

[22] Marchuk, D., Drumm, M., Saulino, A., & Collins, F. S. (1991). Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic acids research, 19(5), 1154.

[23] Szybalski, W., Kim, S. C., Hasan, N., & Podhajska, A. J. (1991). Class-IIS restriction enzymes—a review. Gene, 100, 13-26.

[24] Engler, C., Kandzia, R., & Marillonnet, S. (2008). A one pot, one step, precision cloning method with high throughput capability. PloS one, 3(11), e3647.

[25] Engler, C., Gruetzner, R., Kandzia, R., & Marillonnet, S. (2009). Golden gate shuffling: a one-pot DNA shuffling method based on type IIs restriction enzymes. PloS one, 4(5), e5553.

[26] Sleight, S. C., Bartley, B. A., Lieviant, J. A., & Sauro, H. M. (2010). In-Fusion BioBrick assembly and re-engineering. Nucleic acids research, 38(8), 2624-2636.

[27] Gibson, D. G., Young, L., Chuang, R. Y., Venter, J. C., Hutchison III, C. A., & Smith, H. O. (2009). Enzymatic assembly of DNA molecules up to several hundred kilobases. Nature methods, 6(5), 343-345.

[28] Hartley, J. L., Temple, G. F., & Brasch, M. A. (2000). DNA cloning using in vitro site-specific recombination. Genome research, 10(11), 1788-1795.

[29] Walhout, A. J., Temple, G. F., Brasch, M. A., Hartley, J. L., Lorson, M. A., van den Heuvel, S., & Vidal, M. (2000). [34] GATEWAY recombinational cloning: Application to the cloning of large numbers of open reading frames or ORFeomes. In Methods in enzymology (Vol. 328, pp. 575-IN7). Academic Press.